Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · IEX Real-Time Price · USD
14.62
+0.84 (6.10%)
At close: May 31, 2024, 4:00 PM
14.90
+0.28 (1.88%)
After-hours: May 31, 2024, 6:22 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $761.99 million as of May 31, 2024. Its market cap has increased by 56.34% in one year.
Market Cap
761.99M
Enterprise Value
582.84M
1-Year Change
56.34%
Ranking
Category
Stock Price
$14.62
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $774.00M to $761.99M, a decrease of -1.55%. That is a compound annual growth rate of -0.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 762.00M | 6.10% |
May 30, 2024 | 718.20M | 0.07% |
May 29, 2024 | 717.70M | -2.10% |
May 28, 2024 | 733.10M | -2.38% |
May 24, 2024 | 751.00M | -2.05% |
May 23, 2024 | 766.70M | -6.95% |
May 22, 2024 | 824.00M | 3.00% |
May 21, 2024 | 800.00M | -4.66% |
May 20, 2024 | 839.10M | 15.82% |
May 17, 2024 | 724.50M | -0.92% |
May 16, 2024 | 731.20M | -0.72% |
May 15, 2024 | 736.50M | 10.40% |
May 14, 2024 | 667.10M | 10.81% |
May 13, 2024 | 602.00M | 0.62% |
May 10, 2024 | 598.30M | -4.42% |
May 9, 2024 | 626.00M | 3.54% |
May 8, 2024 | 604.60M | -2.84% |
May 7, 2024 | 622.30M | 0.58% |
May 6, 2024 | 618.70M | 11.16% |
May 3, 2024 | 556.60M | 2.83% |
May 2, 2024 | 541.30M | 1.12% |
May 1, 2024 | 535.30M | 4.82% |
Apr 30, 2024 | 510.70M | -7.01% |
Apr 29, 2024 | 549.20M | -4.42% |
Apr 26, 2024 | 574.60M | 6.15% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
89bio | 777.23M |
Aurinia Pharmaceuticals | 775.16M |
Nuvation Bio | 766.23M |
Cogent Biosciences | 765.86M |
Viridian Therapeutics | 762.68M |
Wave Life Sciences | 756.80M |
OrthoPediatrics | 752.52M |
Scholar Rock Holding | 748.89M |